Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Ceftriaxone, With Adjunctive Clarithromycin, in the Treatment of Adult Subjects With Community-Acquired Pneumonia
Conditions
Interventions
Ceftaroline fosamil for Injection
IV Ceftriaxone
+2 more
Locations
168
United States
Investigational site
Los Angeles, California, United States
Investigational Site
Pasadena, California, United States
Investigational Site
Sacramento, California, United States
Investigational Site
San Diego, California, United States
Investigational Site
Orlando, Florida, United States
Investigational Site
Fort Gordon, Georgia, United States
Start Date
January 1, 2008
Primary Completion Date
December 1, 2008
Completion Date
June 1, 2009
Last Updated
March 14, 2017
NCT06804096
NCT07004049
NCT06162286
NCT07386912
NCT05531149
NCT04215991
Lead Sponsor
Forest Laboratories
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions